Financial reports
20-F
2022 FY
Annual report (foreign)
1 May 23
20-F
2021 FY
Annual report (foreign)
29 Apr 22
20-F
2020 FY
Annual report (foreign)
22 Apr 21
20-F
2019 FY
Annual report (foreign)
30 Apr 20
20-F
2018 FY
Annual report (foreign)
29 Apr 19
20-F
2017 FY
Annual report (foreign)
11 May 18
NT 20-F/A
Notice of late annual filing (foreign) (amended)
8 May 18
NT 20-F
Notice of late annual filing (foreign)
30 Apr 18
20-F
2016 FY
Annual report (foreign)
22 Nov 17
NT 20-F
Notice of late annual filing (foreign)
1 May 17
Current reports
6-K
Current report (foreign)
21 Feb 24
6-K
SINOVAC Reports on the Clinical Trial Progress of its Anti-COVID-19 Antibody SA55 Injection
11 Sep 23
6-K
Sinovac Confirms Receipt of an Unsolicited Partial Tender Offer
29 Aug 23
6-K
Sinovac Announces Change of Legal Representative of Sinovac Beijing
28 Aug 23
6-K
SINOVAC Reports Unaudited First Half of 2023 Financial Results
15 Aug 23
6-K
SINOVAC Reports Unaudited Second Half of 2022 Financial Results and Files 2022 Annual Report on Form 20-F
1 May 23
6-K
Current report (foreign)
28 Apr 23
6-K
Current report (foreign)
22 Feb 23
6-K
SINOVAC Reports Unaudited First Half of 2022 Financial Results
29 Dec 22
6-K
Current report (foreign)
4 Nov 22
Registration and prospectus
SC TO-T/A
Third party tender offer statement (amended)
15 Mar 24
8-A12B/A
Registration of securities on exchange (amended)
21 Feb 24
SC TO-T/A
Third party tender offer statement (amended)
2 Feb 24
SC 14D9
Tender offer solicitation
18 Jan 24
SC TO-T
Third party tender offer statement
8 Jan 24
SC TO-T/A
Third party tender offer statement (amended)
3 Oct 23
SC 14D9
Tender offer solicitation
5 Sep 23
SC TO-T
Third party tender offer statement
24 Aug 23
8-A12B/A
Registration of securities on exchange (amended)
22 Feb 23
8-A12B/A
Registration of securities on exchange (amended)
22 Feb 22
Other
UPLOAD
Letter from SEC
10 Oct 23
CORRESP
Correspondence with SEC
5 Oct 23
UPLOAD
Letter from SEC
8 Sep 23
CORRESP
Correspondence with SEC
1 Sep 23
UPLOAD
Letter from SEC
21 Jul 23
CORRESP
Correspondence with SEC
10 Jul 23
UPLOAD
Letter from SEC
26 Jun 23
CORRESP
Correspondence with SEC
30 Jan 18
UPLOAD
Letter from SEC
22 Jan 18
UPLOAD
Letter from SEC
25 Aug 10
Ownership
SC 13G/A
Advantech Capital L.P.
20 Mar 24
SC 13D/A
SAIF Partners IV L.P.
4 Dec 23
SC 13D/A
SAIF Partners IV L.P.
15 Sep 23
SC 13D/A
SAIF Partners IV L.P.
25 May 23
SC 13D/A
SAIF Partners IV L.P.
15 Mar 23
SC 13D/A
SAIF Partners IV L.P.
12 Dec 22
SC 13D
CDH Fund VI, L.P.
22 Dec 20
SC 13D/A
1Globe Capital LLC
21 Dec 20
SC 13D/A
Sinovac Biotech LTD
19 Mar 19
SC 13D/A
Sinovac Biotech LTD
27 Aug 18